Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot

doi:10.4240/wjgs.v13.i3.231

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8685)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

822

WORD

240

HTML

4884

Figures (1-2)

386

Tables (1-5)

318

Sum=6650

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

492

Download

493

Sum=985

Publishing Process of This Article

Item

Count

Browse

427

Download

623

Sum=1050

Mar 27, 2021 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Surg. Mar 27, 2021; 13(3): 231-255
Published online Mar 27, 2021. doi: 10.4240/wjgs.v13.i3.231

Full Size Figure Download Figure

Figure 2 Surgical and medical management of pancreatic and small intestinal neuroendocrine neoplasms^[^80-91]. GEP: Gastroenteropancreatic; NENs: Neuroendocrine neoplasms; pNENs: Pancreatic NENs; NET: Neuroendocrine tumor; NEC: Neuroendocrine carcinoma; ZES/MEN1: Zollinger Ellison Syndrome with multiple endocrine neoplasia 1; STZ/5FU: Streptozotocin/5-fluorouracil; PRRT: Peptide receptor radionuclide therapy; SSA: Somatostatin analogues; SIRT: Selective internal radiotherapy; TAE: Transarterial embolisation; TACE: Transarterial chemoembolization; CAPTEM: Capecitabine and temozolomide; FOLFOX: Folinic acid, 5-fluorouracil and oxaliplatin; FOLFIRI: Folinic acid, fluorouracil, and irinotecan; CP: Central pancreatectomy; DP: Distal pancreatectomy; PD: Pancreaticoduodenectomy, TP: Total pancreatectomy; G1: Grade 1; G2: Grade 2; G3: Grade 3.

Citation: Fernandez CJ, Agarwal M, Pottakkat B, Haroon NN, George AS, Pappachan JM. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot. World J Gastrointest Surg 2021; 13(3): 231-255
URL: https://www.wjgnet.com/1948-9366/full/v13/i3/231.htm
DOI: https://dx.doi.org/10.4240/wjgs.v13.i3.231